Menu Search
Equities

Hua Medicine

HUMDF:PKC

Hua Medicine

Actions
  • Price (USD)0.150
  • Today's Change0.00 / 0.00%
  • Shares traded186.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 12:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, Hua Medicine increased its cash reserves by 197.74%, or 970.19m. The company earned 889.37m from its operations for a Cash Flow Margin of 1,160.90%. In addition the company generated 8.08m and 69.07m cash from investing and financing, respectively.
Cash flow per share-0.2502
Price/Cash flow per share--
Book value per share-0.0364
Tangible book value per share-0.0667
More ▼

Balance sheet in CNYView more

Hua Medicine has a Debt to Total Capital ratio of 113.87%, a higher figure than the previous year's 42.47%.
Current ratio4.87
Quick ratio4.64
Total debt/total equity--
Total debt/total capital1.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.